Social Media

A drug that slows the affects of multiple sclerosis (MS) has been recommended for treatment on the NHS. The National Institute for Health and Care Excellence (Nice) has published draft guidance which recommends ocrelizumab for treating relapsing-remitting MS in adults. There are around 100,000 people with MS in the UK,…
Researchers have criticised the rejection of a prostate cancer drug they hailed as a "game changer". The Institute of Cancer Research (ICR) said thousands of men a year could be affected by the decision not to recommend abiraterone. The National Institute for Health and Care Excellence (Nice) said on Wednesday…
Up to 850 women in England and Wales could benefit from a targeted pill that treats ovarian cancer after it was approved for use on the NHS through the Cancer Drugs Fund. The National Institute for Health and Care Excellence (Nice) said niraparib will be made available to adults with…
Hundreds of children plagued by a life-shortening disease have written to the Prime Minister begging her for access to a "life-saving" drug. More than 1,000 personal letters are to be delivered to 10 Downing Street, imploring Theresa May to intervene and help patients with cystic fibrosis get access to Orkambi.…
Only one in seven women who are at high risk of breast cancer are taking a preventative drug, a new study suggests. Researchers found that six in seven women with a family history of breast cancer opt out of taking tamoxifen as a preventative medication. In 2013, the National Institute…
Health officials have reversed a decision over whether a genetic test for breast cancer patients should be used by the NHS. The Oncotype DX test was provisionally rejected for use in January, despite having previously been recommended for certain women. The test helps to predict the risk of breast cancer…
Health officials are set to give the green light to a new treatment for a condition which has not seen any advances in almost six decades. The National Institute for Health and Care Excellence is to issue guidance recommending tocilizumab for patients with giant cell arteritis (GCA) for use in…
Sharon Jeffreys from the Mental Health Intensive Support Team, NHS Improvement discusses the National Institute for Health and Care Excellence (NICE)’s learning disabilities guideline and how organisations can work to improve local services. In my former role as a lead commissioner on behalf of four Clinical Commissioning Groups (CCGs) in…
A lack of essential nutrients is known to contribute to the onset of poor mental health in people suffering from anxiety and depression, bipolar disorder, schizophrenia and ADHD. Nutritional psychiatry is a growing discipline that focuses on the use of food and supplements to provide these essential nutrients as part…
A "life-changing" drug for breast cancer patients has been given the final go-ahead for routine NHS use in England. The National Institute for Health and Care Excellence (Nice) issued its final decision recommending Perjeta, also known as pertuzumab, for some women with breast cancer. The drug previously had to be…
Some breast cancer patients could be offered hormone therapy for a decade under new NHS guidelines. And all women who have a mastectomy due to breast cancer should be offered immediate breast reconstruction, under draft National Institute for Health and Care Excellence guidelines. Meanwhile, some women should be offered bisphosphonates…
NICE says that online and mobile programme Deprexis could help adults with depression get faster access to care and it should be tested out in NHS services. Around 200 people in England could benefit from free access to this digital therapy after NICE recommended that it is trialled in specialist…
Page 1 of 3